Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALTEROLA BIOTECH, INC.

(ABTI)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Alterola Biotech, Inc. signed an agreement to acquire the assets from C2 Wellness Corporation for $6.4 million.

11/16/2021 EST

Alterola Biotech, Inc. (OTCPK:ABTI) signed an agreement to acquire the assets from C2 Wellness Corporation for $6.4 million on November 9, 2021. The purchase price is payable with 24 million common shares in Alterola Biotech. The implementation of the transaction has been approved by the board of both companies.


ę S&P Capital IQ 2021
All news about ALTEROLA BIOTECH, INC.
2021ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Alterola Biotech, Inc. Announces Removal of Lalit Kumar Verma as A Director
CI
2021ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Completion of Acquisit..
AQ
2021Alterola Biotech, Inc. completed the acquisition of the assets from C2 Wellness Corpora..
CI
2021Alterola Biotech, Inc. signed an agreement to acquire the assets from C2 Wellness Corpo..
CI
2021ALTEROLA BIOTECH INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
2021ALTEROLA BIOTECH : Board Replaces Outgoing CFO Larson Elsmore With Timothy Rogers as Inter..
MT
2021ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Alterola Biotech, Inc. Announces Executive Changes
CI
2021Alterola Biotech, Inc. Announces Executive Changes
CI
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -0,34 M - -
Net Debt 2021 0,03 M - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 181 M 181 M -
EV / Sales 2020
EV / Sales 2021 -
Nbr of Employees -
Free-Float 15,9%
Chart ALTEROLA BIOTECH, INC.
Duration : Period :
Alterola Biotech, Inc. Technical Analysis Chart | ABTI | US02152V1035 | MarketScreener
Income Statement Evolution
Managers and Directors
Seamus McAuley Chief Executive Officer & Secretary
Timothy Paul Rogers Chairman & Chief Financial Officer
Colin Stott Chief Operating Officer & Director
Dominic Schiller Director
Daniel S. Reshef Director
Sector and Competitors
1st jan.Capi. (M$)
ALTEROLA BIOTECH, INC.57.53%181
GILEAD SCIENCES, INC.-3.00%88 346
REGENERON PHARMACEUTICALS-3.21%63 906
VERTEX PHARMACEUTICALS5.22%58 750
WUXI APPTEC CO., LTD.-5.55%54 178
BIONTECH SE-34.36%40 873